Consider Afrezza as an Alternative to Mealtime Insulin Injections

March 2015

Afrezza (uh-FREZ-uh) will be a new INHALED insulin for diabetes.

The first inhaled insulin, Exubera, didn't pan out...partly because the inhaler was hard to use and about the size of a tennis ball can.

Afrezza is easier to use...and about the size of a whistle.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote